Features and News

ETF Battles: ARKG Vs IDNA Vs GNOM

Join us for a triple-header to determine the best genomics biotech ETF!

Features and News

Broad Vs Narrow Thematic ETFs

What’s better: a diversity of themes or a diversity of stocks in a theme?

Features and News

ARK ETF Investors Not Getting Seasick

In spite of rocky performance in 2021, investors are still betting on ARK Funds’ bright future.

Features and News

ARK ETFs Grind Higher Amid Chop

The Fed’s change in outlook might point to stormier waters ahead for the rebounding ARK suite and other tech-heavy funds.

Features and News

ETF Battles: ARKG Vs GNOM

Which biotech/genomics ETF is the better play?

Features and News

High Flying ETFs Reverse Course

From 'ARKK' to 'SPAK' to 'IPO,' these once-hot ETFs have noticeably cooled.

ETF Report

Awards That Tell A Story

The awards nominees are a microcosm of the ETF space.

Features and News

Cathie Wood Details ‘ARKX’ Vision

Why the time is nigh to shoot for investing in space.

Index Investor Corner

Why Avoiding Alpha A Good ETF Play

What active ARK ETFs and smart beta have in common.